SARS-CoV-2 Positive Serology and Islet Autoantibodies in Newly Diagnosed Pediatric Cases of Type 1 Diabetes Mellitus: A Single-Center Cohort Study

• Published in: International journal of molecular sciences 2023-05, Vol.24 (10), p.8885
• Main Authors: Boboc, Anca Andreea, Novac, Carmen Nicoleta, Marin, Alexandra Gabriela, Ieșanu, Mara Ioana, Plătică, Cristina, Buzescu, Teodora, Coșoreanu, Maria Teodora, Galoș, Felicia
• Format: Article
• Language: English
• Subjects: Age groups; Analysis; Antibodies; Autoantibodies; Autoimmunity; Child; Children; Cohort analysis; Cohort Studies; Coronaviruses; COVID-19; COVID-19 - epidemiology; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Diabetes Mellitus, Type 1; Diabetic ketoacidosis; Diabetic Ketoacidosis - diagnosis; Diabetic Ketoacidosis - epidemiology; Disease; Diseases; Glycated Hemoglobin; Glycosylated hemoglobin; Health aspects; Humans; IA-2A; Infection; Infection in children; Infections; islet autoantibodies; Ketoacidosis; Medical research; Medicine, Experimental; Pandemics; Pathogenesis; Pediatrics; Peptides; Population; Retrospective Studies; SARS-CoV-2; SARS-CoV-2 antibodies; SARS-CoV-2 infection; Serology; Severe acute respiratory syndrome coronavirus 2; Type 1 diabetes; type 1 diabetes mellitus; Vitamin D; Vitamin deficiency
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24108885

Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, although presenting less severe forms of the disease in children, seems to play a role in the development of other conditions, including type 1 diabetes mellitus (T1DM). After the beginning of the pandemic, an increase in the number of T1DM pediatric patients was observed in several countries, thus leading to many questions about the complex relationship between SARS-CoV-2 infection and T1DM. Our study aimed to highlight possible correlations between SARS-CoV-2 serology and T1DM onset. Therefore, we performed an observational retrospective cohort study that included 158 children diagnosed with T1DM in the period April 2021-April 2022. The presence or absence of SARS-CoV-2 and T1DM-specific antibodies and other laboratory findings were assessed. In the group of patients with positive SARS-CoV-2 serology, a higher percentage had detectable IA-2A antibodies, more children were positive for all three islet autoantibodies determined (GADA, ICA, and IA-2A), and a higher mean HbA1c value was found. No difference existed between the two groups regarding DKA presence and severity. A lower C-peptide level was found in the patients presenting diabetic ketoacidosis (DKA) at T1DM onset. When compared to a group of patients diagnosed before the pandemic, an increased incidence of both DKA and severe DKA, as well as a higher age at diagnosis and higher levels of HbA1c were present in our study group. These findings have important implications for the ongoing monitoring and management of children with T1DM after the COVID-19 pandemic and highlight the need for further research to better understand the complex relationship between SARS-CoV-2 infection and T1DM.